Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose atropine for myopia control in children
2020-001575-33Phase 3Active
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Feb 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atropine in myopia (3 arms), sponsored by Universitätsklinikum Freiburg. Primary endpoint: Change in cycloplegic refraction per year. Started Feb 2021; status: active.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2020-001575-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001575-33.